BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 24704825)

  • 81. The lymphocyte adapter protein: A negative regulator of myocardial ischemia/reperfusion injury.
    Huang J; Sun Y; Chen L; Ma G
    J Mol Cell Cardiol; 2019 Sep; 134():107-118. PubMed ID: 31301301
    [TBL] [Abstract][Full Text] [Related]  

  • 82. PRL-3 suppresses c-Fos and integrin α2 expression in ovarian cancer cells.
    Liu H; Al-aidaroos AQ; Wang H; Guo K; Li J; Zhang HF; Zeng Q
    BMC Cancer; 2013 Feb; 13():80. PubMed ID: 23418787
    [TBL] [Abstract][Full Text] [Related]  

  • 83. BTG3 Overexpression Suppresses the Proliferation and Invasion in Epithelial Ovarian Cancer Cell by Regulating AKT/GSK3β/β-Catenin Signaling.
    An Q; Zhou Y; Han C; Zhou Y; Li F; Li D
    Reprod Sci; 2017 Oct; 24(10):1462-1468. PubMed ID: 28183228
    [TBL] [Abstract][Full Text] [Related]  

  • 84. [Effect of Silencing and Overexpression of LNK Gene on STAT3 Expression in THP-1 Cells].
    Tian RM; Shi L; Rong Y; Tan M; Luo X; Su Q; Huang CS; Chen Y
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2019 Oct; 27(5):1469-1475. PubMed ID: 31607300
    [TBL] [Abstract][Full Text] [Related]  

  • 85. Lnk controls mouse hematopoietic stem cell self-renewal and quiescence through direct interactions with JAK2.
    Bersenev A; Wu C; Balcerek J; Tong W
    J Clin Invest; 2008 Aug; 118(8):2832-44. PubMed ID: 18618018
    [TBL] [Abstract][Full Text] [Related]  

  • 86. AKT2 contributes to increase ovarian cancer cell migration and invasion through the AKT2-PKM2-STAT3/NF-κB axis.
    Zheng B; Geng L; Zeng L; Liu F; Huang Q
    Cell Signal; 2018 May; 45():122-131. PubMed ID: 29374601
    [TBL] [Abstract][Full Text] [Related]  

  • 87. Vitamin D-Binding Protein Enhances Epithelial Ovarian Cancer Progression by Regulating the Insulin-like Growth Factor-1/Akt Pathway and Vitamin D Receptor Transcription.
    Huang YF; Wu YH; Cheng WF; Peng SL; Shen WL; Chou CY
    Clin Cancer Res; 2018 Jul; 24(13):3217-3228. PubMed ID: 29476020
    [No Abstract]   [Full Text] [Related]  

  • 88. Upregulated microRNA-15b alleviates ovarian cancer through inhitbition of the PI3K/Akt pathway by targeting LPAR3.
    Li GC; Qin XL; Song HH; Li YN; Qiu YY; Cui SC; Wang YS; Wang H; Gong JL
    J Cell Physiol; 2019 Dec; 234(12):22331-22342. PubMed ID: 31140597
    [TBL] [Abstract][Full Text] [Related]  

  • 89. CADM1 inhibits ovarian cancer cell proliferation and migration by potentially regulating the PI3K/Akt/mTOR pathway.
    Si X; Xu F; Xu F; Wei M; Ge Y; Chenge S
    Biomed Pharmacother; 2020 Mar; 123():109717. PubMed ID: 31865146
    [TBL] [Abstract][Full Text] [Related]  

  • 90. Rap1-GTP-interacting adaptor molecule (RIAM) protein controls invasion and growth of melanoma cells.
    Hernández-Varas P; Coló GP; Bartolomé RA; Paterson A; Medraño-Fernández I; Arellano-Sánchez N; Cabañas C; Sánchez-Mateos P; Lafuente EM; Boussiotis VA; Strömblad S; Teixidó J
    J Biol Chem; 2011 May; 286(21):18492-504. PubMed ID: 21454517
    [TBL] [Abstract][Full Text] [Related]  

  • 91. A small molecule inhibits Akt through direct binding to Akt and preventing Akt membrane translocation.
    Kim D; Sun M; He L; Zhou QH; Chen J; Sun XM; Bepler G; Sebti SM; Cheng JQ
    J Biol Chem; 2010 Mar; 285(11):8383-94. PubMed ID: 20068047
    [TBL] [Abstract][Full Text] [Related]  

  • 92. Adaptor protein LNK promotes anaplastic thyroid carcinoma cell growth via 14-3-3 ε/γ binding.
    Zhong ZM; Chen X; Qi X; Wang XM; Li CY; Qin RJ; Wang SQ; Liang J; Zeng MS; Sun CZ
    Cancer Cell Int; 2020; 20():11. PubMed ID: 31938019
    [TBL] [Abstract][Full Text] [Related]  

  • 93. LNK/SH2B3 loss of function increases susceptibility to murine and human atrial fibrillation.
    Murphy MB; Yang Z; Subati T; Farber-Eger E; Kim K; Blackwell DJ; Fleming MR; Stark JM; Van Amburg JC; Woodall KK; Van Beusecum JP; Agrawal V; Smart CD; Pitzer A; Atkinson JB; Fogo AB; Bastarache JA; Kirabo A; Wells QS; Madhur MS; Barnett JV; Murray KT
    Cardiovasc Res; 2024 Feb; ():. PubMed ID: 38377486
    [TBL] [Abstract][Full Text] [Related]  

  • 94. Clonal hierarchy and allelic mutation segregation in a myelofibrosis patient with two distinct LNK mutations.
    Lasho TL; Tefferi A; Finke C; Pardanani A
    Leukemia; 2011 Jun; 25(6):1056-8. PubMed ID: 21415853
    [No Abstract]   [Full Text] [Related]  

  • 95. Correction to: Oxidized Phospholipids Promote NETosis and Arterial Thrombosis in LNK(SH2B3) Deficiency.
    Circulation; 2022 Jul; 146(4):e13. PubMed ID: 35877838
    [No Abstract]   [Full Text] [Related]  

  • 96. Corrigendum to: The Longevity-Associated SH2B3 (LNK) Genetic Variant: Selected Aging Phenotypes in 379,758 Subjects.
    Kuo CL; Joaquim M; Kuchel GA; Ferrucci L; Harries LW; Pilling LC; Melzer D
    J Gerontol A Biol Sci Med Sci; 2020 Sep; 75(9):1686. PubMed ID: 31783406
    [No Abstract]   [Full Text] [Related]  

  • 97. Correction to: A Single Nucleotide Polymorphism in
    Circ Res; 2023 Mar; 132(5):e95. PubMed ID: 36862815
    [No Abstract]   [Full Text] [Related]  

  • 98. A mechanistic LNK between inflammation and atrial fibrillation?
    Keefe JA; Zhao S; Wehrens XHT
    Cardiovasc Res; 2024 May; ():. PubMed ID: 38713542
    [No Abstract]   [Full Text] [Related]  

  • 99. Linking inflammation and hypertension via LNK/SH2B3.
    Dale BL; Madhur MS
    Curr Opin Nephrol Hypertens; 2016 Mar; 25(2):87-93. PubMed ID: 26717315
    [TBL] [Abstract][Full Text] [Related]  

  • 100. Genomic and Functional Analysis of the E3 Ligase PARK2 in Glioma.
    Lin DC; Xu L; Chen Y; Yan H; Hazawa M; Doan N; Said JW; Ding LW; Liu LZ; Yang H; Yu S; Kahn M; Yin D; Koeffler HP
    Cancer Res; 2015 May; 75(9):1815-27. PubMed ID: 25877876
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.